Thomas L Snelling (Thomas Snelling, Tom Snelling)

Scopus Author ID Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

PLoS medicine

Trials

PLoS computational biology

Pharmacy practice

University of Sydney

Charles Darwin University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sydney

Australia

Professor in Infectious Diseases :: School of Public Health

Telethon Kids Institute

Australia

Team Lead :: Adaptive Health Intelligence

Curtin University Dec 01 2016 - Dec 01 2019

Australia

Adjunct Associate Professor :: School of Public Health

Telethon Kids Institute

Australia

Director, Wesfarmers Centre of Vaccines & Infectious Diseases

University of Western Australia Jan 01 2016 - Dec 31 2018

Australia

Clinical Senior Lecturer :: Centre for Child Health Research

Education History

Charles Darwin University

Australia

PHD :: Menzies School of Health Research

Flinders University

Australia

BSC

Publications

Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter B McIntyre, Heidi Smith-Vaughan, Sue A Skull, Victor Maduabuchi Oguoma, Mark David Chatfield, Deborah Lehmann, Christopher G Brennan-Jones, Michael J Binks, Paul Vincent Licciardi, Ross M Andrews, Thomas L Snelling, Vicki Krause, Jonathan R Carapetis, Anne Bernadette Chang, Peter Stanley Morris
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS medicine 21 (6) (2024)
Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter B McIntyre, Heidi Smith-Vaughan, Sue A Skull, Victor Maduabuchi Oguoma, Mark David Chatfield, Deborah Lehmann, Christopher G Brennan-Jones, Michael J Binks, Paul Vincent Licciardi, Ross M Andrews, Thomas L Snelling, Vicki Krause, Jonathan R Carapetis, Anne Bernadette Chang, Peter Stanley Morris
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS medicine 21 (6) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter B McIntyre, Heidi Smith-Vaughan, Sue A Skull, Victor Maduabuchi Oguoma, Mark David Chatfield, Deborah Lehmann, Christopher G Brennan-Jones, Michael J Binks, Paul Vincent Licciardi, Ross M Andrews, Thomas L Snelling, Vicki Krause, Jonathan R Carapetis, Anne Bernadette Chang, Peter Stanley Morris
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS medicine 21 (6) (2024)
Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter B McIntyre, Heidi Smith-Vaughan, Sue A Skull, Victor Maduabuchi Oguoma, Mark David Chatfield, Deborah Lehmann, Christopher G Brennan-Jones, Michael J Binks, Paul Vincent Licciardi, Ross M Andrews, Thomas L Snelling, Vicki Krause, Jonathan R Carapetis, Anne Bernadette Chang, Peter Stanley Morris
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS medicine 21 (6) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Grace E Currie, James Totterdell, Grahame Bowland, Alan Leeb, Ian Peters, Chris C Blyth, Claire Waddington, Julie A Marsh, Thomas L Snelling
The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage. Trials 24 (1) (2023)
Grace E Currie, James Totterdell, Grahame Bowland, Alan Leeb, Ian Peters, Chris C Blyth, Claire Waddington, Julie A Marsh, Thomas L Snelling
The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage. Trials 24 (1) (2023)
Grace E Currie, James Totterdell, Grahame Bowland, Alan Leeb, Ian Peters, Chris C Blyth, Claire Waddington, Julie A Marsh, Thomas L Snelling
The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage. Trials 24 (1) (2023)
Yue Wu, Steven Mascaro, Mejbah Bhuiyan, Parveen Fathima, Ariel O Mace, Mark P Nicol, Peter C Richmond, Lea-Ann Kirkham, Michael Dymock, David A Foley, Charlie McLeod, Meredith L Borland, Andrew Martin, Phoebe C M Williams, Julie A Marsh, Thomas L Snelling, Christopher C Blyth
Predicting the causative pathogen among children with pneumonia using a causal Bayesian network. PLoS computational biology 19 (3) (2023)
Yue Wu, Steven Mascaro, Mejbah Bhuiyan, Parveen Fathima, Ariel O Mace, Mark P Nicol, Peter C Richmond, Lea-Ann Kirkham, Michael Dymock, David A Foley, Charlie McLeod, Meredith L Borland, Andrew Martin, Phoebe C M Williams, Julie A Marsh, Thomas L Snelling, Christopher C Blyth
Predicting the causative pathogen among children with pneumonia using a causal Bayesian network. PLoS computational biology 19 (3) (2023)
Meg J Jardine, Sradha S Kotwal, Abhinav Bassi, Carinna Hockham, Mark A Jones, Arlen Wilcox, Carol A Pollock, Louise M Burrell, Vijay S Rathore, Christine R Jenkins, Lalit Gupta, Angus Graham Ritchie, Ashpak Bangi, Sanjay D'Cruz, Andrew J McLachlan, Simon R Finfer, Michelle M Cummins, Thomas L Snelling, Vivekananda Jha, null null
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Jessica Ramsay, Julie Marsh, Alisa Pedrana, Nada Andric, Richard Norman, Wendy Cheng, Steve Webb, Nikolajs Zeps, Matthew Bellgard, Todd Graves, Margaret Hellard, Thomas L Snelling
A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C. BMC infectious diseases 20 (1) (2020)
Parveen Fathima, Hannah Catherine Moore, Christopher C Blyth, Thomas L Snelling
Association between rotavirus vaccination and intussusception in Australian children: A record linkage study. Paediatric and perinatal epidemiology 34 (5) (2020)
Mona Mostaghim, Thomas L Snelling, Beata V Bajorek
Agreement between units of measure for paediatric antibiotic utilisation surveillance using hospital pharmacy supply data. Pharmacy practice 17 (3) (2019)
Mona Mostaghim, Thomas L Snelling, Beata V Bajorek
Factors associated with adherence to antimicrobial stewardship after-hours. The International journal of pharmacy practice 27 (2) (2018)
Mona Mostaghim, Thomas L Snelling, Hala Katf, Beata V Bajorek
Paediatric antimicrobial stewardship and safe prescribing: an assessment of medical staff knowledge and behaviour. Pharmacy practice 16 (2) (2018)

Thomas L Snelling.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas Snelling, Tom Snelling)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas L Snelling (Thomas Snelling, Tom Snelling)